Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00962832
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis
INTERVENTIONAL
Inicio: 6 de feb de 2025
ID: NCT06843239
Completado
Fase 2
ClinicalTrials.gov
A Study of ARRY-438162 in Patients With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00650767
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Efficacy and Safety of Daxdilimab in Adult Participants With Active Proliferative Lupus Nephritis
INTERVENTIONAL
Inicio: 26 de abr de 2023
ID: NCT05540665
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 20 de ago de 2021
ID: NCT04882878
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)
INTERVENTIONAL
Inicio: 12 de ene de 2023
ID: NCT05620407
Reclutando
Fase 3
ClinicalTrials.gov
A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)
INTERVENTIONAL
Inicio: 13 de sept de 2022
ID: NCT05531565
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Open-label Study In The Latin America Region Comparing The Safety And Efficacy Of Etanercept With Conventional Dmard Therapy In Subjects With Rheumatoid Arthritis.
INTERVENTIONAL
Inicio: 1 de jun de 2009
ID: NCT00848354
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Branebrutinib Treatment in Subjects With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Subjects With Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 7 de ene de 2020
ID: NCT04186871
Completado
Fase 3
ClinicalTrials.gov
EFFICACY, SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS (JIA) IN CHILDREN AND ADOLESCENT SUBJECTS
INTERVENTIONAL
Inicio: 10 de jun de 2016
ID: NCT02592434
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
INTERVENTIONAL
Inicio: 31 de oct de 2019
ID: NCT04134728
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)
INTERVENTIONAL
Inicio: 15 de jun de 2023
ID: NCT05814627
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat, ACPA-Positive Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 10 de ene de 2025
ID: NCT06754462
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2014
ID: NCT02265705
Desconocido
Fase 3
ClinicalTrials.gov
Multicenter Extension Study To 104 Weeks To Asses The Efficacy, Safety And Immunogenicity Of Enerceptan® In Combination With Methotrexate For The Treatment Of Patients With Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 6 de oct de 2016
ID: NCT03403140
Terminado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo Controlled, Parallel Group, Multi-center, Phase III Trial of Ofatumumab Investigating Clinical Efficacy in Adult Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00611455
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Open-label, Long-term Follow-up Safety and Efficacy Study of GLPG0634 Treatment in Subjects With Moderately to Severely Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 25 de feb de 2014
ID: NCT02065700
Desconocido
ClinicalTrials.gov
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
INTERVENTIONAL
Inicio: 30 de sept de 2019
ID: NCT04061733
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 28 de may de 2021
ID: NCT04925934
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Subjects With Active Radiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 31 de jul de 2015
ID: NCT02438787
Anterior
1
...
13
14
15
...
434
Siguiente
Filtros